Recursion Pharmaceuticals Inc.

NASDAQ: RXRX
Share price (7/10/25): $5.71
Market cap (7/10/25): $2.323 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Insider Ownership

Li Dean Y »

Dar Zavain »

Hershberg Robert »

Sun Elaine D »

Borgeson Blake »

Michor Franziska »

Bumpus Namandje »

Taylor Ben R »

Gibson Christopher »

Khan Najat »

Mauro David J »

Chavez R. Martin »

Virani Shafique »

Bogue Zachary »

Mamoura Diversified Global Holding PJSC »

Mubadala Investment Co PJSC »

Doyle Ramona »

Lux Ventures IV, L.P. »

Lux Venture Partners IV, LLC »

Hebert Peter »

Lux Co-Invest Partners, LLC »

Lux Co-Invest Opportunities, L.P. »

Wolfe Josh »

Mic Capital Partners (Public) (US) Im, LLC »

MIC Capital Partners (Public) Parallel Cayman, LP »

MIC Capital Management UK LLP »

Data Collective IV GP, LLC »

DCVC Opportunity Fund II GP, LLC »

DCVC Opportunity Fund II, L.P. »

Dcvc V GP, LLC »

Dcvc V, L.P. »

Ocko Matthew »

≥5% Ownership

Ra Capital Management, L.P. »

ARK Investment Management LLC »

Baillie Gifford & Co »

BlackRock Inc. »

Marriott Tina »

Secora Michael »

Vanguard Group Inc »

Fmr LLC »

Kinnevik AB (Publ) »

State Street Corporation »

Burrell Terry-Ann »

BlackRock Finance, Inc. »

Lux Capital Management, LLC »

Data Collective IV, L.P. »